OBJECTS: The goal of cerebral arteriovenous malformation (AVM) therapy in pediatric patients should be complete resection or obliteration of the AVM to eliminate subsequent hemorrhage, because of high mortality and morbidity rates related to hemorrhage in addition to the longer life expectation. Despite advances in Gamma knife radiosurgery and in endovascular embolization, surgical resection is still the gold standard for treating cerebral AVMs. METHODS: Between 1986 and 2003, 20 children were surgically treated for cerebral AVMs. The AVMs were graded I, II, and III using the Spetzler-Martin (S-M) Grading Scale. Good recovery was achieved in 18 out of 20 patients (90%) and only 1 patient was moderately disabled (5%). There was one mortality (5%) related to the preoperative deep comatose state of the patient. The total obliteration rate was 89% (17 out of 19). CONCLUSION: For S-M grade I-III AVMs, surgical resection is the treatment of choice, considering its high cure rate and low morbidity and mortality rates.
OBJECTS: The goal of cerebral arteriovenous malformation (AVM) therapy in pediatric patients should be complete resection or obliteration of the AVM to eliminate subsequent hemorrhage, because of high mortality and morbidity rates related to hemorrhage in addition to the longer life expectation. Despite advances in Gamma knife radiosurgery and in endovascular embolization, surgical resection is still the gold standard for treating cerebral AVMs. METHODS: Between 1986 and 2003, 20 children were surgically treated for cerebral AVMs. The AVMs were graded I, II, and III using the Spetzler-Martin (S-M) Grading Scale. Good recovery was achieved in 18 out of 20 patients (90%) and only 1 patient was moderately disabled (5%). There was one mortality (5%) related to the preoperative deep comatose state of the patient. The total obliteration rate was 89% (17 out of 19). CONCLUSION: For S-M grade I-III AVMs, surgical resection is the treatment of choice, considering its high cure rate and low morbidity and mortality rates.
Authors: E I Levy; A Niranjan; T P Thompson; A M Scarrow; D Kondziolka; J C Flickinger; L D Lunsford Journal: Neurosurgery Date: 2000-10 Impact factor: 4.654
Authors: P Lasjaunias; F Hui; M Zerah; R Garcia-Monaco; V Malherbe; G Rodesch; A Tanaka; H Alvarez Journal: Childs Nerv Syst Date: 1995-02 Impact factor: 1.475
Authors: David Rubin; Alejandro Santillan; Jeffrey P Greenfield; Mark Souweidane; Howard A Riina Journal: Childs Nerv Syst Date: 2010-07-02 Impact factor: 1.475
Authors: Thomas M O'Lynnger; Wajd N Al-Holou; Joseph J Gemmete; Aditya S Pandey; B Gregory Thompson; Hugh J L Garton; Cormac O Maher Journal: Childs Nerv Syst Date: 2011-03-26 Impact factor: 1.475
Authors: Jody Filippo Capitanio; Pietro Panni; Alberto Luigi Gallotti; Carmen Rosaria Gigliotti; Francesco Scomazzoni; Stefania Acerno; Antonella Del Vecchio; Pietro Mortini Journal: Childs Nerv Syst Date: 2018-11-24 Impact factor: 1.475
Authors: Christian Dorfer; Thomas Czech; Gerhard Bavinzski; Klaus Kitz; Aygül Mert; Engelbert Knosp; Andreas Gruber Journal: Childs Nerv Syst Date: 2009-11-28 Impact factor: 1.475